Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carolina Varvariuc, Ion IliciucfiledCriticalCarolina Varvariuc
Priority to MDA20050104ApriorityCriticalpatent/MD2904G2/en
Publication of MD2904F1publicationCriticalpatent/MD2904F1/en
Publication of MD2904G2publicationCriticalpatent/MD2904G2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
The invention refers to medicine, namely to pharmacology.Summary of the invention consists in that for treatment of central nervous system affections to children it is used the Gerovital H3 preparation.
MDA20050104A2005-04-122005-04-12Use of Gerovital H3 preparation for treatment of central nervous system affections to children
MD2904G2
(en)
Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease
1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof